摘要:
A method of inflating an airbag with a fluid includes sending a signal to open a first valve and opening the first valve. The method also includes directing a control pressure through the first valve and toward a second valve. The method further includes throttling the second valve in response to the control pressure. The throttling of the second valve produces a variable inflation mass flow rate of the fluid at a second valve outlet. Opening the first valve and closing the first valve are performed as a step function to achieve a desired predetermined variable inflation mass flow rate of the airbag.
摘要:
A method, apparatus, and computer program product are provided for providing a local proxy for accessing web services. An apparatus may include a processor configured to receive, at a proxy service implemented on the apparatus, a first HTTP request from a HTTP protocol client application executed on the apparatus. The first HTTP request may be directed to a first network location, wherein the HTTP client application is associated with the first network location. The processor may be further configured to determine whether the first HTTP request includes an indication of a second network location for circumventing a same-origin policy. The processor may additionally be configured to transmit a second HTTP request to the second network location when the first HTTP request includes an indication of a second network location. Corresponding methods and computer program products are also provided.
摘要:
Compositions, kits and methods are provided for promoting general health or for prevention or treatment of diseases by using novel recombinant fusion proteins of human serum albumin (HSA) and bioactive molecules. The bioactive molecules may be a protein or peptide having a biological function in vitro or in vivo, and preferably, having a therapeutic activity when administered to a human. By fusing the bioactive molecule to HSA, stability of the bioactive molecule in vivo can be improved and the therapeutic index increased due to reduced toxicity and longer-lasting therapeutic effects in vivo. In addition, manufacturing processes are provided for efficient, cost-effective production of these recombinant proteins in yeast.
摘要:
Compositions, kits and methods are provided for promoting general health or for prevention or treatment of diseases by using novel recombinant fusion proteins of human serum albumin (HSA) and bioactive molecules. The bioactive molecules may be a protein or peptide having a biological function in vitro or in vivo, and preferably, having a therapeutic activity when administered to a human. By fusing the bioactive molecule to HSA, stability of the bioactive molecule in vivo can be improved and the therapeutic index increased due to reduced toxicity and longer-lasting therapeutic effects in vivo. In addition, manufacturing processes are provided for efficient, cost-effective production of these recombinant proteins in yeast.
摘要:
Conductive cement-based compositions exhibiting both good electrical conductivity and mechanical strength have been obtained by ensuring proper dispersion of conductive phase within the composition. The content of the ingredients depends on the preparation method, for instance conventional mixing or slurry infiltration, and on the type of the composition, i.e. conductive paste, mortar or concrete. The broad content ranges of the conductive composition are:a cement binder,a conductive phase consisting of one or more of the following:conductive fibers in the amount from 0 to 15% by volume of the composition;conductive particles in the amount from 0 to 80% by volume of the composition;water, at the weight ratio relative to cement binder from 0.2 to 0.75,fine agregates at the weight ratio relative to cement binder from 0.0 to 2.0, andcoarse aggregates at the weight ratio relative to cement binder from 0.0 to 2.0,conventional additives or admixtures, and optionally a dispersant.Exemplary compositions obtained according to the invention have a 28-day d.c. resistivity of 0.46-43 .OMEGA.cm and 28-day compressive strength of 35-71 MPa.